Department of Cardiology and Angiology II, University Heart Center Freiburg Bad Krozingen, Suedring 15, 79189, Bad Krozingen, Germany.
Department of Internal Medicine and Cardiology, Klinikum Wuerzburg Mitte, Würzburg, Germany.
Clin Res Cardiol. 2023 Sep;112(9):1175-1185. doi: 10.1007/s00392-022-02094-z. Epub 2022 Sep 8.
This study investigated the contemporary incidence and predictors of radial artery occlusion as well as the effectiveness of antithrombotic treatment for radial artery occlusion following transradial coronary angiography.
The radial artery is the standard access for coronary angiography and even complex interventions. Postprocedural radial artery occlusion is still a common and significant complication.
This prospective study enrolled 2004 patients following transradial coronary angiography. After sheath removal, hemostasis was obtained in a standardized fashion. Radial artery patency was evaluated by duplex ultrasonography in all patients. In case of occlusion, oral anticoagulation was recommended and patients were scheduled for a 30-day follow-up including Doppler ultrasonography.
A new-diagnosed radial occlusion was found in 4.6% of patients. The strongest independent predictors of radial occlusion were female sex and active smoking status. In the subgroup of patients with percutaneous coronary interventions, female sex followed by sheath size > 6 French were the strongest predictors of radial occlusion. 76 of 93 patients with radial occlusion received an oral anticoagulation for 30 days. However, reperfusion at 30 days was found in 32% of patients on oral anticoagulation.
The incidence of radial artery occlusion following coronary angiography in contemporary practice appears with 4.6% to be lower as compared to previous cohorts. Female sex and smoking status are the strongest independent predictors of radial occlusion followed by procedural variables. The limited effectiveness of oral anticoagulation for treatment of radial artery occlusion suggests a primarily traumatic than thrombotic mechanism of this complication.
本研究旨在调查经桡动脉冠状动脉造影术后桡动脉闭塞的当代发生率和预测因素,以及抗栓治疗对桡动脉闭塞的有效性。
桡动脉是冠状动脉造影甚至复杂介入治疗的标准入路。术后桡动脉闭塞仍然是一种常见且严重的并发症。
本前瞻性研究纳入了 2004 例行经桡动脉冠状动脉造影的患者。拔除鞘管后,采用标准化方法进行止血。所有患者均行双功能超声检查评估桡动脉通畅情况。一旦发生闭塞,建议口服抗凝治疗,并安排患者在 30 天内进行随访,包括多普勒超声检查。
新发桡动脉闭塞的发生率为 4.6%。桡动脉闭塞的最强独立预测因素是女性和吸烟状态。在经皮冠状动脉介入治疗的亚组中,女性和鞘管大小>6 French 是桡动脉闭塞的最强预测因素。93 例桡动脉闭塞患者中有 76 例接受了 30 天的口服抗凝治疗。然而,在接受口服抗凝治疗的患者中,30 天时再通率为 32%。
与以往队列相比,当代经冠状动脉造影术后桡动脉闭塞的发生率为 4.6%,似乎较低。女性和吸烟状态是桡动脉闭塞的最强独立预测因素,其次是操作变量。口服抗凝治疗治疗桡动脉闭塞的效果有限,提示这种并发症主要是创伤性的,而不是血栓性的。